Improvement of skin barrier function during treatment of atopic dermatitis

J Am Acad Dermatol. 1995 Dec;33(6):969-72. doi: 10.1016/0190-9622(95)90288-0.

Abstract

Background: Active dermatitis causes a disturbance in skin barrier function. This can be evaluated by the measurement of transepidermal water loss (TEWL) and percutaneous absorption of hydrocortisone.

Objective: The study objective was to evaluate changes in skin barrier function during treatment of atopic dermatitis.

Methods: Nine patients with widespread atopic dermatitis were studied longitudinally by measuring the severity of the dermatitis and TEWL at intervals of 1 to 3 days. Percutaneous absorption of hydrocortisone was measured at entry and during treatment.

Results: At entry, both TEWL and percutaneous absorption of hydrocortisone were elevated. Four to six days later, a significant decline was observed in both variables, indicating rapid improvement in skin barrier function. Individual changes in TEWL correlated with the changes in the systemic absorption of hydrocortisone.

Conclusion: TEWL reflects changes in the systemic absorption of topical hydrocortisone during treatment of atopic dermatitis.

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Analysis of Variance
  • Anti-Inflammatory Agents / pharmacokinetics
  • Anti-Inflammatory Agents / therapeutic use
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / physiopathology*
  • Female
  • Humans
  • Hydrocortisone
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Skin / drug effects
  • Skin / physiopathology*
  • Skin Absorption / physiology
  • Statistics, Nonparametric
  • Time Factors
  • Water Loss, Insensible / drug effects
  • Water Loss, Insensible / physiology

Substances

  • Anti-Inflammatory Agents
  • Hydrocortisone